Article -> Article Details
Title | Xanthoma Market Regional Analysis, Key Players and Forecasts by 2023 |
---|---|
Category | Fitness Health --> Addictions |
Meta Keywords | Xanthoma Market |
Owner | vinit |
Description | |
Market Highlights High levels of blood lipids, or fats, hyperlipidemia, or
high blood cholesterol levels, diabetes, cancer, hypothyroidism, biliary
cirrhosis, cholestasis, nephrotic syndrome, hematologic diseases such as
monoclonal gammopathy and other metabolic disorders are some of the risk
factors of xanthoma. Side effect of certain medications, such as tamoxifen,
prednisone, cyclosporine, and others may hamper the market growth over the
review period. Rising demand due to growing population, increasing
screening, greater emphasis on restorative procedures, rising safety, and
success of xanthoma treatment are driving the market growth. However, the
complications such as risk of bleeding, infections, pain, especially, during
surgery, high cost of xanthoma treatment, and poor understanding of the disease
may restrain the market growth. The global Xanthoma
market is expected to grow at a CAGR of ~ 6.0 % during the
forecast period 2017-2023. There is no preventive treatment for xanthoma which, is the
single most unmet need in the market. Product development represents the best
strategy for the market growth. The market is expected to witness an
exponential growth over the review period owing to technological advancement in
surgical procedures. Market development is another strategy for as there is a
large unmet need in the developing regions such as India and China. Cost of the
product is likely to a decisive factor in the developing regions such as Asia
Pacific and, especially, Africa. Key Market Players Some of the key players profiled in the report are
AstraZeneca PLC, GlaxoSmithKline PLC, Johnson & Johnson, Bayer HealthCare
Pharmaceuticals LLC, Pfizer, Inc., Novartis International AG, Teva pharmaceutical
industries, Novo Nordisk, Sanofi and others. Regional Analysis Europe is the second largest market in the world due to
growing pharmaceutical industry and healthcare penetration. The European market
growth is led by countries such as Germany and France. Germany is expected to
be the fastest growing market over the assessment period due to its large
pharmaceutical industry. Asia Pacific region is expected to grow rapidly; China and
India are likely to lead this market due to the fast growing healthcare sector
and large unmet needs over the forecast period. South East Asian countries such
as China, India, and Malaysia are projected to contribute highly to the market
growth. The growing penetration of the healthcare industry in the Asia Pacific
region is expected to drive the future market in the region. Gulf nations such as Saudi Arabia and the UAE are estimated
to drive the Middle East & African market. Other Middle East nations to
watch out for are Kuwait, Jordan, Egypt, and Iran. The African region is
expected to witness a poor growth owing to poor economic and political conditions,
and poor healthcare development. Other regions are expected to be laggards due
to poor social development and tribal identities such as sub-Saharan Africa. Taste the market data and market information presented
through more than 50 market data tables and figures spread over 80 pages of the
project report. Avail the in-depth table of content (TOC) & market synopsis
on “Global Xanthoma Market” Research Report – Forecast till 2023. Segmentation The global market has been segmented on the basis of types,
diagnosis, treatment, and end user. Based on the types, the market has been segmented as
xanthelasma, xanthoma tuberosum, xanthoma tendinosum, eruptive xanthoma,
xanthoma planum, palmar xanthoma, tuberoeruptive xanthoma, and others. Based on the diagnosis, the market has been segmented as
physical examination, biopsy, blood tests, and others. Based on the treatment, the market has been segmented as
drugs, surgery, chemical treatment, and others. Based on the end user, the market has been segmented as hospitals
and clinics, research and academics, and others. |